Atorvastatin Calcium Tablet
Product Images NDC 71335-2591

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71335-2591). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 01)

Chemical structure of atorvastatin calcium, depicting the molecular arrangement including phenyl rings, fluorophenyl group, hydroxyl groups, and calcium ion complex.*

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 02)

A line graph showing cumulative incidence percentage on the Y-axis over a period of 3.5 years on the X-axis. Two lines are compared: a solid line for Atorvastatin and a dashed line for Placebo, with Atorvastatin consistently showing lower cumulative incidence. The graph includes a hazard ratio (HR=0.64) with confidence interval and a p-value indicating statistical significance.*

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 03)

A line graph comparing cumulative hazard percentages over five years of follow-up for Atorvastatin and placebo groups. The x-axis shows time in years, and the y-axis shows cumulative hazard percentage. The chart includes a hazard ratio (HR 0.63) with confidence intervals and a p-value indicating statistical significance.*

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 04)

A Kaplan-Meier plot comparing the time to first major cardiovascular event over five years between subjects taking Atorvastatin 10 mg and 80 mg. The y-axis shows the percentage of subjects experiencing the event, with the 80 mg group represented by a solid line and the 10 mg group by a dotted line. The chart includes a hazard ratio of 0.78 (95% CI 0.69-0.89) with a P-value of 0.0002.*

FDA Label Image

Label (Lbl713352591)

Label for Atorvastatin Calcium Tablets, USP 40 mg, oral tablets, repackaged by Bryant Ranch Prepack and manufactured by Graviti Pharmaceuticals Pvt. Ltd. The label includes storage instructions (20-25°C), a QR code for the package insert, and a package count of 30 tablets. The label shows NDC 71335-2591-1 with barcodes and other regulatory text.*

FDA Label Image

Label (Lbl7133525912)

Atorvastatin Calcium 40 mg tablet label from Bryant Ranch Prepack, packaged in Burbank, CA 91504. The label indicates a white oval tablet and includes storage instructions to keep at room temperature (20°-25°C). It references comparison to Lipitor 40 mg, lists a package count of 30 tablets, and shows the NDC 71335-2591.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.